Corcept Therapeutics | CORT - Ebit

Stock Price
32.15
Daily Change
-0.24 -0.74%
Monthly
-18.87%
Yearly
-42.60%
Q1 Forecast
31.18

Corcept Therapeutics reported $4.49M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Acadia Pharmaceuticals USD 17.39M 18.36M Dec/2025
Alaunos Therapeutics USD -1.19M 148K Sep/2025
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Ardelyx USD 7.12M 19.62M Sep/2025
Aurora Cannabis CAD -44.75M 27.14M Sep/2025
BioMarin Pharmaceutical USD 198.39M 230.08M Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Canopy Growth CAD -14.3M 17.19M Sep/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Esperion Therapeutics USD -16.03M 11.51M Sep/2024
J&J USD 5.11B 2.3B Dec/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Lexicon Pharmaceuticals USD -49.63M 5.39M Sep/2023
Merck USD 6.24B 1.32B Dec/2025
Nektar Therapeutics USD -34.34M 3.68M Sep/2024
Novartis USD -9.19B 13.87B Jun/2025
Novartis USD 4.48B 343M Sep/2025
Omeros USD -48.15M 7.25M Sep/2023
Pacira USD 3.19M 9.96M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
TG Therapeutics USD 50.49M 21.13M Dec/2025